Contents

Current Cancer Therapy Reviews, Volume 8 - Number 1

Editorial

, 8(1): 1

Kurt S. Zaenker


DOI: 10.2174/157339412799462477




Editorial [Hot Topic: The Current World Health Organization Classification of the Myeloproliferative and Myelodysplastic/myeloproliferative Neoplasms and Correlation with Pertinent Targeted Therapy (Guest Editor: Cherie H. Dunphy)]

, 8(1): 2

Cherie H. Dunphy


DOI: 10.2174/157339412799462468




Chronic Myelogenous Leukemia

, 8(1): 3 - 13

Robert P. Hasserjian


DOI: 10.2174/157339412799462486




Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable

, 8(1): 14 - 29

Robert P. Hasserjian


DOI: 10.2174/157339412799462495




Chronic Eosinophilic Leukemia, Not Otherwise Specified (CEL, NOS)

, 8(1): 30 - 34

Cherie H. Dunphy


DOI: 10.2174/157339412799462512




Mastocytosis

, 8(1): 35 - 43

Tracy I. George


DOI: 10.2174/157339412799462549




Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB or FGFR1

, 8(1): 44 - 51

Cherie H. Dunphy


DOI: 10.2174/157339412799462503




Myelodysplastic/Myeloproliferative Neoplasms

, 8(1): 52 - 65

Cherie H. Dunphy


DOI: 10.2174/157339412799462530




Personalized Diabetes and Cancer Medicine: A Rationale for Anti-Diabetic Nutrition (Bitter Melon) in a Supportive Setting

, 8(1): 66 - 77

Zanker K.S., Mang B., Wolters M and Hahn A.


DOI: 10.2174/157339412799462521




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science